21 May 2019
Visiongain has launched a new pharma report Urology Devices Market Report: Urinary Incontinence, Benign Prostatic Hyperplasia, Kidney Stone, Prostate Cancer.
In 2018, the urology devices market is estimated at $6.9 billion. The market is expected to grow at a CAGR of 6.1% from 2018 to 2029. Products included in the urology devices market include catheters, slings, brachytherapy, radiation therapy devices, accessories and others. The urinary incontinence market dominated the market in 2018 and accounted for 33.8% of the urology devices market.
The lead analyst of the report commented "The market is driven by a number of factors such as aging population, technological advancements, and increasing awareness programs. Other factors contributing to the growth of the market are preference for minimally invasive procedures and rising incidence of obesity. The market has certain restraining factors such as high cost of devices and social stigma associated with the disease."
Leading companies featured in the report include C.R. Bard, Coloplast, Endo Pharmaceuticals, Boston Scientific Corporation, Healthtronics, Lumenis, Medtronic, Siemens Healthcare, Urologix and other companies.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.
12 April 2021
Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.
09 April 2021
The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.
06 April 2021
Factors such as increasing data volumes for analysis, quick turnaround time for the discovery and development new drug, computing power, AI also helps in targeted manufacturing and others drive the market growth.